Medicare Rx Must Address “Anger” Over Drug Prices, AARP’s Rother Says
Executive Summary
AARP remains convinced that Congress needs to address the high price of prescription drugs
You may also be interested in...
Reimportation In North America Is Inevitable, Roche Suggests; EU Is Model
A U.S./Canada pharmaceutical importation system may be inevitable, Roche Global Pharmaceutical Head William Burns suggested during an Oct. 16 investor conference call
AARP Supports Canadian Imports To Place “Downward Pressure” On Rx Costs
AARP is endorsing prescription drug reimportation from Canada as a measure to help control the cost of drugs
Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx
The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation